CRE26-054: Germline BARD1 Mutation and Exceptional Response to FOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) - A Case Report.
Publication/Presentation Date
3-31-2026
Volume
24
Issue
3.5
ISSN
1540-1413
Published In/Presented At
Ganesh, B., Jain, A., Yeo, C. J., & Bashir, B. (2026). CRE26-054: Germline BARD1 Mutation and Exceptional Response to FOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) - A Case Report. Journal of the National Comprehensive Cancer Network : JNCCN, 24(3.5), CRE26-054. https://doi.org/10.6004/jnccn.2025.7462
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
42055029
Department(s)
Administration and Leadership
Document Type
Article
COinS